Will those exposed receive any immediate benefits from taking potassium iodide pills now?

Article

In response to the radiation spreading from the No. 3 reactor of the Fukushima Daiichi nuclear complex in Japan, sales of potassium iodide have soared. Some have claimed, however, that the short-term benefits of the drug are a myth, as the radioiodine is less likely to be inhaled, and more likely to be ingested in the future, often from drinking milk produced from cows grazing in areas affected by radiation fallout.

In response to the radiation spreading from the No. 3 reactor of the Fukushima Daiichi nuclear complex in Japan, sales of potassium iodide have soared. Some have claimed, however, that the short-term benefits of the drug are a myth, as the radioiodine is less likely to be inhaled, and more likely to be ingested in the future, often from drinking milk produced from cows grazing in areas affected by radiation fallout.

 

Related Videos
The use of a single-port robot may allow for surgically treating more patients with head and neck cancer in a more timely manner, according to Hilary McCrary, MD, MPH.
Treatment with toripalimab does not yield the same vascular toxicity seen with pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma, according to Barbara Burtness, MD.
Overall survival also appears to improve with toripalimab compared with chemotherapy among patients with metastatic or advanced nasopharyngeal carcinoma.
Eric J. Sherman, MD, highlights several drugs that are being used to treat RET-positive thyroid cancer.
Related Content